| Abbreviation | Definition |
| α-MSH | Alpha-melanocyte-stimulating hormone |
| AKT | Protein kinase B |
| ATM | Ataxia telangiectasia mutated |
| ATR | Ataxia telangiectasia and Rad3-related |
| bFGF | Basic fibroblast growth factor |
| CDK1 | Cyclin-dependent kinase 1 |
| cAMP | Cyclic adenosine monophosphate |
| CHK1 | Checkpoint kinase 1 |
| CHK2 | Checkpoint kinase 2 |
| CPD | Cyclobutane pyrimidine dimer |
| DDR | DNA damage response |
| DMEM | Dulbecco’s modified Eagle’s medium |
| DPBS | Dulbecco’s phosphate-buffered saline |
| EB | Embryoid body |
| EGF | Epidermal growth factor |
| FACS | Fluorescence-activated cell sorting |
| FBS | Fetal bovine serum |
| GADD45α | Growth arrest and DNA damage-inducible protein alpha |
| GFP | Green fluorescent protein |
| GUSB | Beta-glucuronidase |
| γH2AX | Phosphorylated histone H2AX |
| HRP | Horseradish peroxidase |
| iPSC | Induced pluripotent stem cell |
| IRDS | Interferon-related DNA damage resistance signature |
| MAPK | Mitogen-activated protein kinase |
| MC1R | Melanocortin 1 receptor |
| MITF | Microphthalmia-associated transcription factor |
| MX2 | Myxovirus resistance protein 2 |
| NAMs | New Approach Methodologies |
| nbUVB | Narrowband ultraviolet B |
| NER | Nucleotide excision repair |
| NHM | Normal human melanocytes |
| OSKM | OCT4, SOX2, KLF4, and c-MYC |
| PARP | Poly(ADP-ribose) polymerase |
| PBS | Phosphate-buffered saline |
| PKA | Protein kinase A |
| PMA | Phorbol 12-myristate 13-acetate |
| PMEL | Premelanosome protein |
| QC | Quality control |
| ROS | Reactive oxygen species |
| RPPA | Reverse phase protein array |
| RT-qPCR | Quantitative reverse-transcription polymerase chain reaction |
| SCF | Stem cell factor |
| SSEA-4 | Stage-specific embryonic antigen 4 |
| STAT1 | Signal transducer and activator of transcription 1 |
| TG | Test guideline |
| TYR | Tyrosinase |
| UV | Ultraviolet |
| XAF1 | XIAP-associated factor 1 |